Defining stem cell types: Understanding the therapeutic potential of ESCs, ASCs, and iPS cells

Journal of Molecular Endocrinology

Volumn 49, Issue 2, 2012, Pages

  Alvarez, Clara V ^a   Garcia Lavandeira, Montserrat ^a   Garcia Rendueles, Maria E R ^a   Diaz Rodriguez, Esther ^a   Garcia Rendueles, Angela R ^a   Perez Romero, Sihara ^a   Vila, Tania Vila ^a   Rodrigues, Joana S ^a   Lear, Pamela V ^a   Bravo, Susana B ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL LINE; CELL MATURATION; CELL TRANSFER; CELL TYPE; CLINICAL TRIAL (TOPIC); DIMERIZATION; EMBRYONIC STEM CELL; GENE SWITCHING; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL NUCLEAR TRANSFER;

ADULT; ANIMALS; BETA CATENIN; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CLINICAL TRIALS AS TOPIC; EMBRYONIC STEM CELLS; GRAFT REJECTION; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; PLURIPOTENT STEM CELLS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84866381534     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0072     Document Type: Review

References (157)

1. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, Paz N, Koren-Michowitz M, Waldman D, Leider-Trejo L et al. 2009 Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Medicine 6 e1000029. (doi:10.1371/journal.pmed.1000029)
2. Anversa P, Kajstura J, Leri A & Loscalzo J 2011 Tissue-specific adult stem cells in the human lung. Nature Medicine 17 1038-1039. (doi:10.1038/nm.2463)
3. Baker M 2012 Reprogramming: faithful reporters. Nature Methods 9 231-234. (doi:10.1038/nmeth.1899)
4. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ et al. 2007 Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 1003-1007. (doi:10.1038/nature06196)
5. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N et al. 2007 Human cardiac stem cells. PNAS 104 14068-14073. (doi:10.1073/pnas.0706760104)
6. Bibikova M, Laurent LC, Ren B, Loring JF & Fan JB 2008 Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell 2 123-134. (doi:10.1016/j.stem.2008.01.005)
7. Bilic J & Izpisua Belmonte JC 2012 Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells 30 33-41. (doi:10.1002/stem.700)
8. Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS et al. 2002 Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. PNAS 99 2344-2349. (doi:10.1073/pnas.022438099)
9. Blair K, Wray J & Smith A 2011 The liberation of embryonic stem cells. PLoS Genetics 7 e1002019. (doi:10.1371/journal.pgen.1002019)
10. Blanpain C, Lowry WE, Geoghegan A, Polak L & Fuchs E 2004 Selfrenewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118 635-648. (doi:10.1016/j.cell.2004.08.012)
11. Blasco MA, Serrano M & Fernandez-Capetillo O 2011 Genomic instability in iPS: time for a break. EMBO Journal 30 991-993. (doi:10.1038/emboj.2011.50)
12. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH et al. 2011 Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144 439-452. (doi:10.1016/j.cell.2010.12.032)
13. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T et al. 2011 Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378 1847-1857. (doi:10.1016/S0140-6736(11)61590-0)
14. Bonaguidi MA, Wheeler MA, Shapiro JS, Stadel RP, Sun GJ, Ming GL & Song H 2011 In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics. Cell 145 1142-1155. (doi:10.1016/j.cell.2011.05.024)
15. Borovski T, De Sousa E, Melo F, Vermeulen L & Medema JP 2011 Cancer stem cell niche: the place to be. Cancer Research 71 634-639. (doi:10.1158/0008-5472.CAN-10-3220)
16. Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ, Williams DJ, Kahler DJ, Yamaki M, Davidow L et al. 2011 A functionally characterized test set of human induced pluripotent stem cells. Nature Biotechnology 29 279-286. (doi:10.1038/nbt.1783)
17. Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes SM, Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA et al. 2007 Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448 191-195. (doi:10.1038/nature05950)
18. Buehr M, Meek S, Blair K, Yang J, Ure J, Silva J, McLay R, Hall J, Ying QL & Smith A 2008 Capture of authentic embryonic stem cells from rat blastocysts. Cell 135 1287-1298. (doi:10.1016/j.cell.2008. 12.007)
19. Burke ZD & Tosh D 2012 Ontogenesis of hepatic and pancreatic stem cells. Stem Cell Reviews 8 586-596. (doi:10.1007/s12015-012-9350-2)
20. Carey BW, Markoulaki S, Hanna JH, Faddah DA, Buganim Y, Kim J, Ganz K, Steine EJ, Cassady JP, Creyghton MP et al. 2011 Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9 588-598. (doi:10.1016/j.stem.2011.11.003)
21. Castinetti F, Davis SW, Brue T & Camper SA 2011 Pituitary stem cell update and potential implications for treating hypopituitarism. Endocrine Reviews 32 453-471. (doi:10.1210/er.2010-0011)
22. Chamberlain SJ, Chen PF, Ng KY, Bourgois-Rocha F, Lemtiri-Chlieh F, Levine ES & Lalande M 2010 Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. PNAS 107 17668-17673. (doi:10.1073/pnas.1004487107)
23. Chambers I & Tomlinson SR 2009 The transcriptional foundation of pluripotency. Development 136 2311-2322. (doi:10.1242/dev. 024398)
24. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S & Smith A 2003 Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 643-655. (doi:10.1016/S0092-8674(03)00392-1)
25. Chen J, Gremeaux L, Fu Q, Liekens D, Van Laere S & Vankelecom H 2009 Pituitary progenitor cells tracked down by side population dissection. Stem Cells 27 1182-1195. (doi:10.1002/stem.51)
26. Cheshier SH, Morrison SJ, Liao X & Weissman IL 1999 In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. PNAS 96 3120-3125. (doi:10.1073/pnas. 96.6.3120)
27. Cheung TH, Quach NL, Charville GW, Liu L, Park L, Edalati A, Yoo B, Hoang P & Rando TA 2012 Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 482 524-528. (doi:10.1038/nature10834)
28. Chou YF, Chen HH, Eijpe M, Yabuuchi A, Chenoweth JG, Tesar P, Lu J, McKay RD & Geijsen N 2008 The growth factor environment defines distinct pluripotent ground states in novel blastocystderived stem cells. Cell 135 449-461. (doi:10.1016/j.cell.2008. 08.035)
29. Claudinot S, Nicolas M, Oshima H, Rochat A & Barrandon Y 2005 Long-term renewal of hair follicles from clonogenic multipotent stem cells. PNAS 102 14677-14682. (doi:10.1073/pnas. 0507250102)
30. Clayton E, Doupe DP, Klein AM, Winton DJ, Simons BD & Jones PH 2007 A single type of progenitor cell maintains normal epidermis. Nature 446 185-189. (doi:10.1038/nature05574)
31. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V et al. 2006 Human mesenchymal stem cells modulate B-cell functions. Blood 107 367-372. (doi:10.1182/blood-2005-07-2657)
32. Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M, Orwig KE, Wolgemuth DJ & Pandolfi PP 2004 Essential role of Plzf in maintenance of spermatogonial stem cells. Nature Genetics 36 653-659. (doi:10.1038/ng1367)
33. Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, Wang S, Morton CC, McMahon AP, Powers D et al. 2004 Derivation of embryonic stem-cell lines from human blastocysts. New England Journal of Medicine 350 1353-1356. (doi:10.1056/NEJMsr040330)
34. Cyranoski D 2012 The darker side of stem cells. Nature 483 5. (doi:10.1038/483005a)
35. D'Amario D, Fiorini C, Campbell PM, Goichberg P, Sanada F, Zheng H, Hosoda T, Rota M, Connell JM, Gallegos RP et al. 2011 Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circulation Research 108 857-861. (doi:10.1161/CIRCRESAHA. 111.241380)
36. DeWitt N 2007 Hwang's clone was really a partenote, daley's report. In The Niche: Stem Cells Blog.
37. Di Stasi A, Tey SK, Dotti G, Fujita Y, Kennedy-Nasser A, Martinez C, Straathof K, Liu E, Durett AG, Grilley B et al. 2011 Inducible apoptosis as a safety switch for adoptive cell therapy. New England Journal of Medicine 365 1673-1683. (doi:10.1056/NEJMoa1106152)
38. Duffy MM, Pindjakova J, Hanley SA, McCarthy C, Weidhofer GA, Sweeney EM, English K, Shaw G, Murphy JM, Barry FP et al. 2011 Mesenchymal stem cell inhibition of T-helper 17 celldifferentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. European Journal of Immunology 41 2840-2851. (doi:10.1002/eji.201141499)
39. Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, McMahon A, Rao M & Pevny L 2004 SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Developmental Neuroscience 26 148-165. (doi:10.1159/000082134)
40. English K, Barry FP & Mahon BP 2008 Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunology Letters 115 50-58. (doi:10.1016/j.imlet. 2007.10.002)
41. Erdo F, Buhrle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, FockingM, Kustermann E, Kolossov E, Hescheler J et al. 2003 Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. Journal of Cerebral Blood Flow and Metabolism 23 780-785. (doi:10.1097/01.WCB.0000071886.63724.FB)
42. Evans MJ & Kaufman MH 1981 Establishment in culture of pluripotential cells from mouse embryos. Nature 292 154-156. (doi:10.1038/292154a0)
43. Fauquier T, Rizzoti K, Dattani M, Lovell-Badge R & Robinson IC 2008 SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. PNAS 105 2907-2912. (doi:10.1073/pnas.0707886105)
44. Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH & Magness ST 2009 Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. American Journal of Physiology. Gastrointestinal and Liver Physiology 296 G1108-G1118. (doi:10.1152/ajpgi. 00004.2009)
45. Fuchs E & Horsley V 2011 Ferreting out stem cells from their niches. Nature Cell Biology 13 513-518. (doi:10.1038/ncb0511-513)
46. Fugazzola L, Cirello V & Beck-Peccoz P 2011 Fetal microchimerism as an explanation of disease. Nature Reviews. Endocrinology 7 89-97. (doi:10.1038/nrendo.2010.216)
47. Galofre JC & Davis TF 2007 Microchimerism in thyroid disease. Hot Thyroidology 2.
48. Garcia-Castro J, Alemany R, Cascallo M, Martinez-Quintanilla J, Arriero Mdel M, Lassaletta A, Madero L & Ramirez M 2010 Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study. Cancer Gene Therapy 17 476-483. (doi:10.1038/cgt.2010.4)
49. Garcia-Lavandeira M, Quereda V, Flores I, Saez C, Diaz-Rodriguez E, Japon MA, Ryan AK, Blasco MA, Dieguez C, MalumbresMet al. 2009 A GRFa2/Prop1/stem (GPS) cell niche in the pituitary. PLoS ONE 4 e4815. (doi:10.1371/journal.pone.0004815)
50. Garcia-Lavandeira M, Diaz-Rodriguez E, Garcia-Rendueles ME, Rodrigues JS, Perez-Romero S, Bravo SB & Alvarez CV 2010 Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary. Frontiers of Hormone Research 38 127-138.
51. Garcia-Lavandeira M, Saez C, Diaz-Rodriguez E, Perez-Romero S, Senra A, Dieguez C, Japon MA & Alvarez CV 2012 Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. Journal of Clinical Endocrinology and Metabolism 97 E80-E87. (doi:10.1210/jc.2011-2187)
52. Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C & Rodriguez-Montes JA 2005 A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Diseases of the Colon and Rectum 48 1416-1423. (doi:10.1007/s10350-005-0052-6)
53. Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, Kyeyune R, Vernay B, Jacques TS, Taketo MM, Le Tissier P et al. 2011 Increased wingless (wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. PNAS 108 11482-11487. (doi:10.1073/pnas. 1101553108)
54. Ghannam S, Pene J, Torcy-Moquet G, Jorgensen C & Yssel H 2010 Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. Journal of Immunology 185 302-312. (doi:10.4049/jimmunol.0902007)
55. Gilyarov AV 2008 Nestin in central nervous system cells. Neuroscience and Behavioral Physiology 38 165-169. (doi:10.1007/s11055-008-0025-z)
56. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E et al. 2011 Somatic coding mutations in human induced pluripotent stem cells. Nature 471 63-67. (doi:10.1038/nature09805)
57. Greaves MF 2006 Cord blood donor cell leukemia in recipients. Leukemia 20 1633-1634. (doi:10.1038/sj.leu.2404293)
58. Guenther MG, Frampton GM, Soldner F, Hockemeyer D, MitalipovaM, Jaenisch R & Young RA 2010 Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7 249-257. (doi:10.1016/j.stem. 2010.06.015)
59. Gutierrez-Fernandez M, Rodriguez-Frutos B, Alvarez-Grech J, Vallejo-Cremades MT, Exposito-Alcaide M, Merino J, Roda JM & Diez-Tejedor E 2011 Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience 175 394-405. (doi:10.1016/j.neuroscience. 2010.11.054)
60. Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW & Jaenisch R 2010 Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. PNAS 107 9222-9227. (doi:10.1073/pnas. 1004584107)
61. Hatano SY, Tada M, Kimura H, Yamaguchi S, Kono T, Nakano T, Suemori H, Nakatsuji N & Tada T 2005 Pluripotential competence of cells associated with nanog activity. Mechanisms of Development 122 67-79. (doi:10.1016/j.mod.2004.08.008)
62. Hirabayashi M, Kato M, Sanbo M, Kobayashi T, Hochi S & Nakauchi H 2010 Rat transgenesis via embryonic stem cells electroporated with the kusabira-orange gene. Molecular Reproduction and Development 77 474. (doi:10.1002/mrd.21181)
63. Hockemeyer D, Soldner F, Beard C, Gao Q, MitalipovaM, DeKelver RC, Katibah GE, Amora R, Boydston EA, Zeitler B et al. 2009 Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nature Biotechnology 27 851-857. (doi:10.1038/nbt.1562)
64. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC et al. 2011 Genetic engineering of human pluripotent cells using TALE nucleases. Nature Biotechnology 29 731-734. (doi:10.1038/nbt.1927)
65. Holland AM, Elefanty AG & Stanley EG 2009 Pancreatic differentiation from pluripotent stem cells: tweaking the system. Cell Research 19 395-396. (doi:10.1038/cr.2009.37)
66. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K & Yamanaka S 2009 Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460 1132-1135. (doi:10.1038/nature08235)
67. Hough SR, Clements I, Welch PJ & Wiederholt KA 2006 Differentiation of mouse embryonic stem cells after RNA interferencemediated silencing of OCT4 and nanog. Stem Cells 24 1467-1475. (doi:10.1634/stemcells.2005-0475)
68. Hsu YC, Pasolli HA & Fuchs E 2011 Dynamics between stem cells, niche, and progeny in the hair follicle. Cell 144 92-105. (doi:10.1016/j.cell.2010.11.049)
69. Hwang WS, Roh SI, Lee BC, Kang SK, Kwon DK, Kim S, Kim SJ, Park SW, Kwon HS, Lee CK et al. 2005 Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 308 1777-1783. (doi:10.1126/science.1112286)
70. Jiang H, Shukla A, Wang X, Chen WY, Bernstein BE & Roeder RG 2011 Role for dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell 144 513-525. (doi:10.1016/j.cell.2011.01.020)
71. Kajstura J, RotaM, Hall SR, Hosoda T, D'Amario D, Sanada F, Zheng H, Ogorek B, Rondon-Clavo C, Ferreira-Martins J et al. 2011 Evidence for human lung stem cells. New England Journal of Medicine 364 1795-1806. (doi:10.1056/NEJMoa1101324)
72. Karbanova J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerova H, Jaszai J, Ehrmann J, Kolar Z, Liebers C et al. 2008 The stem cell marker CD133 (prominin-1) is expressed in various human glandular epithelia. Journal of Histochemistry and Cytochemistry 56 977-993. (doi:10.1369/jhc.2008.951897)
73. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA & Frenette PS 2006 Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124 407-421. (doi:10.1016/j.cell.2005.10.041)
74. Kawamata M & Ochiya T 2010 Generation of genetically modified rats from embryonic stem cells. PNAS 107 14223-14228. (doi:10.1073/pnas.1009582107)
75. Kelly KF, Ng DY, Jayakumaran G, Wood GA, Koide H & Doble BW2011 b-Catenin enhances oct-4 activity and reinforces pluripotency through a TCF-independent mechanism. Cell Stem Cell 8 214-227. (doi:10.1016/j.stem.2010.12.010)
76. Kennedy D 2006 Editorial retraction. Science 311 335. (doi:10.1126/science.1124926)
77. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C & Morrison SJ 2005 SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 1109-1121. (doi:10.1016/j.cell.2005.05.026)
78. Kiel MJ, He S, Ashkenazi R, Gentry SN, Teta M, Kushner JA, Jackson TL & Morrison SJ 2007 Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature 449 238-242. (doi:10.1038/nature06115)
79. Kim AC, Reuter AL, Zubair M, Else T, Serecky K, Bingham NC, Lavery GG, Parker KL & Hammer GD 2008 Targeted disruption of b-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 135 2593-2602. (doi:10.1242/dev.021493)
80. Kim J, Su SC, Wang H, Cheng AW, Cassady JP, Lodato MA, Lengner CJ, Chung CY, Dawlaty MM, Tsai LH et al. 2011 Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell 9 413-419. (doi:10.1016/j.stem.2011.09.011)
81. Klein AM, Nakagawa T, Ichikawa R, Yoshida S & Simons BD 2010 Mouse germ line stem cells undergo rapid and stochastic turnover. Cell Stem Cell 7 214-224. (doi:10.1016/j.stem.2010.05.017)
82. Klonisch T & Drouin R 2009 Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease. Trends in Molecular Medicine 15 510-518. (doi:10.1016/j.molmed. 2009.09.002)
83. Kopp JL, Ormsbee BD, Desler M & Rizzino A 2008 Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26 903-911. (doi:10.1634/stemcells.2007-0951)
84. Kriegstein A & Alvarez-Buylla A 2009 The glial nature of embryonic and adult neural stem cells. Annual Review of Neuroscience 32 149-184. (doi:10.1146/annurev.neuro.051508.135600)
85. Lee J, Kanatsu-Shinohara M, Inoue K, Ogonuki N, Miki H, Toyokuni S, Kimura T, Nakano T, Ogura A & Shinohara T 2007 Akt mediates self-renewal division of mouse spermatogonial stem cells. Development 134 1853-1859. (doi:10.1242/dev.003004)
86. Li P, Tong C, Mehrian-Shai R, Jia L, Wu N, Yan Y, Maxson RE, Schulze EN, Song H, Hsieh CL et al. 2008 Germline competent embryonic stemcells derived fromrat blastocysts. Cell 135 1299-1310. (doi:10.1016/j.cell.2008.12.006)
87. Liu L & Rando TA 2011 Manifestations and mechanisms of stem cell aging. Journal of Cell Biology 193 257-266. (doi:10.1083/jcb. 201010131)
88. Liu L, Luo GZ, Yang W, Zhao X, Zheng Q, Lv Z, Li W, Wu HJ, Wang L, Wang XJ et al. 2010 Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. Journal of Biological Chemistry 285 19483-19490. (doi:10.1074/jbc.M110. 131995)
89. Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S & Shi S 2011 Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-g and TNF-a. Nature Medicine 17 1594-1601. (doi:10.1038/nm.2542)
90. Lucas D, Battista M, Shi PA, Isola L & Frenette PS 2008 Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 3 364-366. (doi:10.1016/j.stem.2008.09.004)
91. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R & McKay R 2001 Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292 1389-1394. (doi:10.1126/science.1058866)
92. Lyashenko N, Winter M, Migliorini D, Biechele T, Moon RT & Hartmann C 2011 Differential requirement for the dual functions of b-catenin in embryonic stem cell self-renewal and germ layer formation. Nature Cell Biology 13 753-761. (doi:10.1038/ncb2260)
93. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M & Blasco MA 2009a Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4 141-154. (doi:10.1016/j.stem.2008.12.010)
94. Marion RM, Strati K, Li H, Murga M, Blanco R, Ortega S, Fernandez-Capetillo O, Serrano M & Blasco MA 2009b A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460 1149-1153. (doi:10.1038/nature08287)
95. Martin GR 1981 Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. PNAS 78 7634-7638. (doi:10.1073/pnas.78.12.7634)
96. Mazumdar J, O'Brien WT, Johnson RS, LaManna JC, Chavez JC, Klein PS & Simon MC 2010 O2 regulates stem cells through Wnt/b-catenin signalling. Nature Cell Biology 12 1007-1013. (doi:10.1038/ncb2102)
97. McMahon MA, Rahdar M & Porteus M 2011 Gene editing: not just for translation anymore. Nature Methods 9 28-31. (doi:10.1038/nmeth.1811)
98. Mendez-Ferrer S, Lucas D, Battista M & Frenette PS 2008 Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452 442-447. (doi:10.1038/nature06685)
99. Mendez-Ferrer S, Michurina TV, Ferraro F, MazloomAR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN & Frenette PS 2010 Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466 829-834. (doi:10.1038/nature09262)
100. Meng X, Lindahl M, Hyvonen ME, Parvinen M, de Rooij DG, Hess MW, Raatikainen-Ahokas A, Sainio K, Rauvala H, Lakso M et al. 2000 Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 287 1489-1493. (doi:10.1126/science.287.5457.1489)
101. Merkle FT, Mirzadeh Z & Alvarez-Buylla A 2007 Mosaic organization of neural stem cells in the adult brain. Science 317 381-384. (doi:10.1126/science.1144914)
102. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M & Yamanaka S 2003 The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113 631-642. (doi:10.1016/S0092-8674(03)00393-3)
103. Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C & Kahn M 2007 Wnt/b-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. PNAS 104 5668-5673. (doi:10.1073/pnas.0701331104)
104. Miyanari Y & Torres-Padilla ME 2012 Control of ground-state pluripotency by allelic regulation of nanog. Nature 483 470-473. (doi:10.1038/nature10807)
105. Moretti A, BellinM, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Hohnke C, Hofmann F et al. 2010 Patient-specific induced pluripotent stem-cell models for long-QT syndrome. New England Journal of Medicine 363 1397-1409. (doi:10.1056/NEJMoa0908679)
106. Ng HH & Surani MA 2011 The transcriptional and signalling networks of pluripotency. Nature Cell Biology 13 490-496. (doi:10.1038/ncb0511-490)
107. Niwa H & Fujimori T 2010 Stem cell systems in development of mammals. Development, Growth & Differentiation 52 251. (doi:10.1111/j.1440-169X.2010.01181.x)
108. Niwa H, Burdon T, Chambers I & Smith A 1998 Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes and Development 12 2048-2060. (doi:10.1101/gad.12. 13.2048)
109. Niwa H, Miyazaki J & Smith AG 2000 Quantitative expression of oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics 24 372-376. (doi:10.1038/74199)
110. Oatley JM, Avarbock MR & Brinster RL 2007 Glial cell line-derived neurotrophic factor regulation of genes essential for self-renewal of mouse spermatogonial stem cells is dependent on src family kinase signaling. Journal of Biological Chemistry 282 25842-25851. (doi:10.1074/jbc.M703474200)
111. O'Donoghue K 2006 Implications of fetal stem cell trafficking in pregnancy. Reviews in Gynaecological and Perinatal Practice 6 87-98. (doi:10.1016/j.rigapp.2005.11.001)
112. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ et al. 2011 Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nature Cell Biology 13 541-549. (doi:10.1038/ncb2239)
113. Ohm JE, Mali P, Van Neste L, Berman DM, Liang L, Pandiyan K, Briggs KJ, Zhang W, Argani P, Simons B et al. 2010 Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Research 70 7662-7673. (doi:10.1158/0008-5472.CAN-10-1361)
114. Okita K, Ichisaka T & Yamanaka S 2007 Generation of germlinecompetent induced pluripotent stem cells. Nature 448 313-317. (doi:10.1038/nature05934)
115. Okita K, Nakagawa M, Hyenjong H, Ichisaka T & Yamanaka S 2008 Generation of mouse induced pluripotent stem cells without viral vectors. Science 322 949-953. (doi:10.1126/science.1164270)
116. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K et al. 2011 A more efficient method to generate integration-free human iPS cells. Nature Methods 8 409-412. (doi:10.1038/nmeth.1591)
117. Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R et al. 2006 Homeodomain-mediated b-catenin-dependent switching events dictate cell-lineage determination. Cell 125 593-605. (doi:10.1016/j.cell.2006.02.046)
118. Peljto M, Dasen JS, Mazzoni EO, Jessell TM & Wichterle H 2010 Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation. Cell Stem Cell 7 355-366. (doi:10.1016/j.stem.2010.07.013)
119. Pera MF & Tam PP 2010 Extrinsic regulation of pluripotent stem cells. Nature 465 713-720. (doi:10.1038/nature09228)
120. Peterson SE, Tran HT, Garitaonandia I, Han S, Nickey KS, Leonardo T, Laurent LC & Loring JF 2011 Teratoma generation in the testis capsule. Journal of Visualized Experiments 57 e3177.
121. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA & Wysocka J 2011 A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470 279-283. (doi:10.1038/nature09692)
122. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB & Cornelius JG 2000 Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nature Medicine 6 278-282. (doi:10.1038/73128)
123. Rando TA 2005 The adult muscle stem cell comes of age. Nature Medicine 11 829-831. (doi:10.1038/nm0805-829)
124. Relaix F, Rocancourt D, Mansouri A & Buckingham M 2005 A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 435 948-953. (doi:10.1038/nature03594)
125. Reubinoff BE, Pera MF, Fong CY, Trounson A & Bongso A 2000 Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnology 18 399-404. (doi:10.1038/74447)
126. da Rocha ST, Edwards CA, Ito M, Ogata T & Ferguson-Smith AC 2008 Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends in Genetics 24 306-316. (doi:10.1016/j.tig.2008.03.011)
127. Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, Randell SH & Hogan BL 2009 Basal cells as stem cells of the mouse trachea and human airway epithelium. PNAS 106 12771-12775. (doi:10.1073/pnas.0906850106)
128. Saha K, Mei Y, Reisterer CM, Pyzocha NK, Yang J, Muffat J, Davies MC, Alexander MR, Langer R, Anderson DG et al. 2011 Surfaceengineered substrates for improved human pluripotent stem cell culture under fully defined conditions. PNAS 108 18714-18719. (doi:10.1073/pnas.1114854108)
129. Saito T, Kuang JQ, Bittira B, Al-Khaldi A & Chiu RC 2002 Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Annals of Thoracic Surgery 74 19-24 (discussion 24). (doi:10.1016/S0003-4975(02)03591-9)
130. Sakai K, Yamamoto A, Matsubara K, Nakamura S, NaruseM, YamagataM, Sakamoto K, Tauchi R, Wakao N, Imagama S et al. 2012 Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuroregenerative mechanisms. Journal of Clinical Investigation 122 80-90. (doi:10.1172/JCI59251)
131. Sangiorgi E & Capecchi MR 2008 Bmi1 is expressed in vivo in intestinal stemcells. Nature Genetics 40 915-920. (doi:10.1038/ng.165)
132. Schu S, Nosov M, O'Flynn L, Shaw G, Treacy O, Barry F, Murphy M, O'Brien T & Ritter T 2012 Immunogenicity of allogeneic mesenchymal stem cells. Journal of Cellular and Molecular Medicine. In press. (doi:10.1111/j.1582-4934.2011.01509.x)
133. Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C, Barker N, Klein AM, van Rheenen J, Simons BD et al. 2010 Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143 134-144. (doi:10.1016/j.cell.2010.09.016)
134. Snyder EY & Teng YD 2012 Stem cells and spinal cord repair. New England Journal of Medicine 366 1940-1942. (doi:10.1056/NEJMcibr1200138)
135. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA & Martin F 2000 Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49 157-162. (doi:10.2337/diabetes.49.2.157)
136. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC & Moretta L 2008 Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111 1327-1333. (doi:10.1182/blood-2007-02-074997)
137. Steinhauser ML, Bailey AP, Senyo SE, Guillermier C, Perlstein TS, Gould AP, Lee RT & Lechene CP 2012 Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolism. Nature 481 516-519. (doi:10.1038/nature10734)
138. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F & Abbondanzo SJ 1992 Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359 76-79. (doi:10.1038/359076a0)
139. Suga H, Kadoshima T, Minaguchi M, Ohgushi M, Soen M, Nakano T, Takata N, Wataya T, Muguruma K, Miyoshi H et al. 2011 Selfformation of functional adenohypophysis in three-dimensional culture. Nature 480 57-62. (doi:10.1038/nature10637)
140. Suh H, Consiglio A, Ray J, Sawai T, D'Amour KA & Gage FH 2007 In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2C neural stem cells in the adult hippocampus. Cell Stem Cell 1 515-528. (doi:10.1016/j.stem.2007.09.002)
141. Takahashi K & Yamanaka S 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 663-676. (doi:10.1016/j.cell.2006.07.024)
142. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K & Yamanaka S 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 861-872. (doi:10.1016/j.cell.2007.11.019)
143. Tang F, Barbacioru C, Bao S, Lee C, Nordman E, Wang X, Lao K & Surani MA 2010 Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-seq analysis. Cell Stem Cell 6 468-478. (doi:10.1016/j.stem.2010.03.015)
144. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL & McKay RD 2007 New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448 196-199. (doi:10.1038/nature05972)
145. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS & Jones JM 1998 Embryonic stem cell lines derived from human blastocysts. Science 282 1145-1147. (doi:10.1126/science.282.5391.1145)
146. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M & Fuchs E 2004 Defining the epithelial stem cell niche in skin. Science 303 359-363. (doi:10.1126/science.1092436)
147. Uccelli A, Moretta L & Pistoia V 2008 Mesenchymal stem cells in health and disease. Nature Reviews. Immunology 8 726-736. (doi:10.1038/nri2395)
148. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A et al. 2011 The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477 90-94. (doi:10.1038/nature10357)
149. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA & Gough NM 1988 Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336 684-687. (doi:10.1038/336684a0)
150. Wilmut I, Schnieke AE, McWhir J, Kind AJ & Campbell KH 1997 Viable offspring derived from fetal and adult mammalian cells. Nature 385 810-813. (doi:10.1038/385810a0)
151. Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, Kemler R & Smith A 2011 Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nature Cell Biology 13 838-845. (doi:10.1038/ncb2267)
152. Xu X, D'Hoker J, Stange G, Bonne S, De Leu N, Xiao X, Van de Casteele M, Mellitzer G, Ling Z, Pipeleers D et al. 2008 b Cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132 197-207. (doi:10.1016/j.cell.2007.12.015)
153. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P & Smith A 2008 The ground state of embryonic stem cell self-renewal. Nature 453 519-523. (doi:10.1038/nature06968)
154. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells. Science 318 1917-1920. (doi:10.1126/science.1151526)
155. Zapata AG 2012 Bone marrow stroma: a source of mesenchymal stem cells for cell therapy. In Stem Cells in Human Reproduction: Basic Science and Therapeutic Potential, 3rd edn. Eds C Simon, A Pellicer & RA Reijo Pera. New York: Cambridge University Press.
156. Zhao T, Zhang ZN, Rong Z & Xu Y 2011 Immunogenicity of induced pluripotent stem cells. Nature 474 212-215. (doi:10.1038/nature09971)
157. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y et al. 2009 Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4 381-384. (doi:10.1016/j.stem. 2009.04.005)